Record Details

CMFRI develops a seaweed-based natural treatment for fatty liver disease News Track dated 27th September 2022

CMFRI Repository

View Archive Info
 
 
Field Value
 
Relation http://eprints.cmfri.org.in/16335/
https://english.newstracklive.com/news/cmfri-develops-a-seaweedbased-natural-treatment-for-fatty-liver-disease-sc53-nu318-ta318-1251630-1.html
 
Title CMFRI develops a seaweed-based natural treatment for fatty liver disease News Track dated 27th September 2022
 
Creator CMFRI, Library
 
Subject Seaweed
CMFRI News Clippings
 
Description To treat non-alcoholic fatty liver disease, the Central Marine Fisheries Research Institute (CMFRI) in this city has developed a nutraceutical product using specific seaweeds (NAFLD). The product, known as CadalminTM LivCure extract, is a special combination of 100 percent natural bioactive compounds derived from seaweeds using environmentally friendly green technology to enhance liver function.
 
Publisher News Track
 
Date 2022
 
Type Article
NonPeerReviewed
 
Format text
 
Language en
 
Identifier http://eprints.cmfri.org.in/16335/1/News%20Track_27-09-2022.pdf
CMFRI, Library (2022) CMFRI develops a seaweed-based natural treatment for fatty liver disease News Track dated 27th September 2022. News Track.